CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$489.66

Market cap

$6.5B

P/E Ratio

26.67

Dividend/share

$2.4

EPS

$18.36

Enterprise value

$6.72B

?
Relative Growth: Rel. Growth: 43
Relative Strength: Rel. Strength: 61
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 69

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
The revenue rose by 2.1% year-on-year
The price to earnings (P/E) is 16% higher than the last 4 quarters average of 23.0 but 6% lower than the 5-year quarterly average of 28.3
The debt has soared by 65% since the previous quarter and by 63% year-on-year
Chemed's quick ratio has plunged by 54% YoY and by 20% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com
Peers: SXT BCPC RPM

Key stats

What are the main financial stats of CHE

CHE stock price

How has the Chemed stock price performed over time
Intraday
1.83%
1 week
8.06%
1 month
17.37%
1 year
3.91%
YTD
14.44%
QTD
5.14%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.54B
Gross profit
$822.54M
Operating income
$328.07M
Net income
$259.78M
Gross margin
32.4%
Net margin
10.2%
The net margin is down by 18% year-on-year and by 2.9% since the previous quarter
The operating margin has decreased by 17% YoY and by 3.7% QoQ
Chemed's operating income has decreased by 16% YoY and by 3% from the previous quarter
The net income has declined by 16% year-on-year and by 2.1% since the previous quarter

Price vs fundamentals

How does CHE's price correlate with its fundamentals

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
CHE P/E details
P/E
26.67
P/B
7.95
P/S
2.64
EV/EBIT
19.15
EV/EBITDA
16.13
EV/Sales
2.65
The price to earnings (P/E) is 16% higher than the last 4 quarters average of 23.0 but 6% lower than the 5-year quarterly average of 28.3
The EPS has decreased by 11% YoY
The P/B is 30% more than the last 4 quarters average of 6.1 but 4.2% less than the 5-year quarterly average of 8.3
Chemed's equity has decreased by 28% YoY and by 13% from the previous quarter
CHE's P/S is 22% below its 5-year quarterly average of 3.4 but 6% above its last 4 quarters average of 2.5
The revenue rose by 2.1% year-on-year

Efficiency

How efficient is Chemed business performance
The ROS has decreased by 17% YoY and by 2.1% from the previous quarter
The company's return on invested capital fell by 15% YoY and by 2.5% QoQ
The ROA has declined by 9% year-on-year
The ROE has grown by 6% from the previous quarter but it has contracted by 2.7% YoY

Dividends

What is CHE's dividend history
Dividend details
DPS
$2.4
Dividend yield
0.49%
Payout ratio
13.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Chemed financials performed over time
Chemed's total assets is 123% higher than its total liabilities
Chemed's quick ratio has plunged by 54% YoY and by 20% from the previous quarter
CHE's current ratio has plunged by 51% YoY and by 19% from the previous quarter
The debt is 72% smaller than the equity
CHE's debt to equity has surged by 133% year-on-year and by 87% since the previous quarter
The debt has soared by 65% since the previous quarter and by 63% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.